Cytoplasmic DNM2 expression on the basis of the median H‐score (=285) as the cut‐off demonstrated that while 119 (56.9%) cases expressed low levels, 90 (43.1%) bladder cancer samples showed high levels of cytoplasmic expression of DNM2. Here, DNM2 is linked to urinary bladder cancer.